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Abstract 
As a chemotherapeutic agent heavily used since 1969, Doxorubicin’s (Doxo) mission is well known 
and carried out, in a variety of cancers. Doxo halts cancerous cell replication and causes 
cancerous cells to die through inducing cellular apoptosis. The necessary concentration for this 
to happen and the way in which these interactions are carried out at molecular level is still under 
debate. We use a dual beam optical tweezers to trap and isolate a single DNA molecule so that 
we can explore the binding of Doxo at the single molecule level.  Stretching the DNA molecule in 
the presence of various concentrations of Doxo allow us to quantify the binding and better 
understand this complex interaction. Traditional stretch and release experiments in the presence 
of Doxo displayed that Doxo binding was not in equilibrium. To obtain the equilibrium binding 
properties, the DNA was stretched and held at a constant force, allowing the drug ample time to 
bind to the DNA.   The equilibrium extensions of DNA upon binding to various concentrations of 
Doxo was obtained at four different constant forces. One dimensional lattice binding model, 
McGhee - von Hippel Model, was used obtain the binding affinity at each force and extrapolated 
to obtain the binding affinity in the absence of force, Kd (0) = 1087 ± 187 nM.  This very first 
characterization of Doxo binding to DNA at the single molecule level also yields the extension of 
the DNA upon a single intercalation event, ∆𝑥eq = 0.40 ± 0.02 nm.  The time scale of in which Doxo 
reaches binding equilibrium with DNA and the extension obtained upon single binding event 
challenges the well believed notion that Doxo is a simple classical intercalator. Understanding 
the binding mechanisms of Doxo to DNA at the single molecule level plays a key role to design 
new and improved cancer drugs for the future. 
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Introduction 
The Red Devil 
The Red Devil1, alternatively called Red Death2 are nicknames for anticancer drug, Doxorubicin 
(Doxo) due to the horrifically brutal side effects it causes to some of the patients already suffering 
from cancer1.  Doxo was extracted from a bacterium species named Streptomyces peucetius in  
1969 and introduced under the name of Adriyamicin3, one of the first two anthracycline cancer 
drugs4. Doxo is typically used on cancer patients experiencing boundless cancer progression, and 
in most cases Doxo is directly injected into patient’s veins to treat multiple types of cancers 
including lymphoma, leukemia, and breast cancer5 to name only a few. If the dosage is not 
absolutely perfect then it can cause the patient to suffer cardiotoxic related side effects, where 
it can further escalate into death6.  
Since the introduction of Doxo in 1969 it has become one of the most used drugs worldwide as a 
treatment for cancers with many trade names Adriyamicin®, and Rubex®. Unfortunately, the 
binding mechanism of Doxo at molecular level with the DNA is still not clearly understood. 
Understanding this interaction is important because cancer occurs due to the rapid replication of 
cells, forming what is called a tumor and this process is controlled by DNA. Through the next few 
sections of the introduction I will graze over what exactly cancer is, how it is controlled by DNA, 
along with the fundament components of DNA, followed by the way in which Doxo inserts itself 
into the picture as a therapeutic agent. 
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What Exactly is Cancer? 
Cancer. The dreaded word that tears families apart; a word that is ultimately recognized as being 
a death sentence. Cancer is not only a problem in the United States but across the world. 
Highlighting the United States in particular, as of 2019 it was found that cancer was the second 
leading cause of death in the country, second only to heart disease7.  
Every living organism is made up by cells and these cells divide and multiply to generate more 
cells. This is a crucial part of life as it allows for growth and the replacement of dead cells. Cancer 
is defined broadly as a disease caused by an uncontrollable division of cells in some part of the 
body. 
The question that many ask; “Is it possible for a cure?” In many cases cancer can be a treatable 
disease with the key being early detection. There are four possible ways to combat this abnormal 
cell growth: (1) doctors surgically remove the mass (2) radiation therapy (3) the body attacks the 
cancerous cells naturally (4) chemotherapy or another type of medication8.  
The human body is wonderfully adapted to naturally combat antagonistic cells through the use 
of the immune system. Some cancerous cells though can evade the immune system and its 
ultimate destruction to proliferate further. When the cells multiply in an uncontrollable fashion, 
they will begin to clump up to form the well-known term, tumor. A tumor is not only found in the 
breasts, but also the lungs, brain, and many other parts on the body.  
One may ask: well, why do cells divide and multiply uncontrollably in the first place? Now this 
question opens pandoras box. When a cell becomes cancerous it can happen through a variety 
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of mechanisms:  missing/or altered proteins, DNA replication errors, environmental factors and 
so much more9. 
One way to stop the constant reproduction of the cancerous cell is to target the DNA, which can 
be done using chemotherapeutic agents, such as Doxo. To understand how this is done we must 
first discuss DNA and cell reproduction, which will be addressed in the next two subsections. 
 
DNA (The Genetic Alphabet) 
Since Darwin proposed the theory of evolution in 1859, DNA and proteins were debated as the 
genetic material of cells until 1944 when Oswald Avery proved that indeed DNA was the genetic 
material (The interesting history of the back and forth debate during this period is highlighted in 
appendix 1).The only fact that was known about DNA structure at that time was that the DNA 
was composed of four bases; adenine (A), cytosine (C), guanine (G), thymine (T) whose chemical 


























Adenine Thymine Guanine Cytosine
Figure 1: Cartoons representing chemical structures of the four nucleotide bases in DNA. 
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Erwin Chargaff in 1951 compared the amount of the four base pairs in samples of DNA from 
different organisms. Chargaff would conclude that each organism had the same amount of 
adenine (A) as thymine (T) and  the same amount of guanine (G) as cytosine (C) in their DNA11. 
This discovery is vital today and known as Chargaff’s Rules 
which led to the concept of somehow adenine pairs up with 
thymine and guanine with cytosine to form the DNA structure.  
It was not until 1953 when Rosalind Franklin and Maurice 
Wilkins produced the x-ray crystallography image12 that James 
Watson and Francis Crick used to determine that DNA forms a 
double helix structure13. In this structure the long chain of DNA 
was produced by nucleotides linked together through the 
phosphates; this sugar-phosphate generally referred to as the 
“backbone” is shown in Figure 2. The phosphate end is labeled 
as 5’ end, and sugar end is labeled as 3’ end. 
Combined with Chargaff’s Rule, Watson and Crick discovered that adenine and thymine will pair 
through two hydrogen bonds while guanine and cytosine will pair through three to create the 
double helix structure. A diagram showing the hydrogen bonding between the two sets of bases 






















Figure 2:  A cartoon representation 
of the DNA backbone. The pentose 
rings (orange) of the nucleotides are 
bonded through covalent bonds to 
the phosphate groups (purple).  The 
bases are represented by the four-
colored bubble. 
 







The double helix structure of DNA looks like a twisted ladder and is often referred to as double 
stranded DNA (dsDNA)12. The DNA gets its strength and shape as the base pairs (steps of the 
ladder) stack on top of each other and more pi-pi bonding interactions are created13. These base 
pairs (bp) in the DNA structure are formed 0.34 nm apart with 10 bp creating a full rotation of 
the double helix. The negatively charged phosphate backbone on each side of the DNA running 
antiparallel to each other, which can be observed through the 3’ and 5’ notation. This twisting of 
the DNA creates a groove pattern in the DNA with major and minor grooves, which alternates 






























Adenine - Thymine Guanine - Cytosine
Figure 3: The electronegative atoms nitrogen, and oxygen form the two hydrogen bonds (red broken 
lines) between the adenine and thymine bases and the three between guanine and cytosine bases. 
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Cell Reproduction and DNA Replication  
The human body has roughly 10 trillion cells, each containing DNA that is 2 meters (m) in length. 
One maybe asking themselves well how does something that is 2 meters in length fit inside a cell 
that is only a micron in thickness, or a tenth of the diameter of a strand of hair? 
The negatively charged DNA is wrapped around a positively charged protein called a histone, 
which condense in groups of 8 forming what is called nucleosomes14,15. This complex of DNA and 
proteins in then referred to as chromatin. Chromatin will then be coiled into a further higher 












Figure 4: Simple illustration of obtaining a double helix structure by twisting a ladder (left). A detailed 
representation of the backbone and base pairs of the DNA in 2-dimension (middle). Schematic showing the major 
and minor grooves of the double helix and a full rotation of 10 bp rising 3.4 nm (right). 
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All living things are composed of cells that are constantly dying and being recreated. This process 
is especially important for an organism to undergo growth and development. As I mentioned 
earlier, it becomes detrimental when a cell begins to divide uncontrollably though, and this is 
when it will typically be deemed cancerous. In order for a cell to function properly it requires the 
information that is embedded in the DNA. Therefore, when a cell divides to create two new cells 
the DNA has to be copied and replicated. Due to the way in which the DNA is packaged into 
chromosomes, it requires special enzymes to help in the unwinding process. Enzymes are a form 
of protein that acts as a catalyst to assist in a chemical reaction. There are two primary enzymes 
that help with this unwinding process, topoisomerase and helicase. These enzymes along with 
many other factors need to be precisely coordinated with one another during the replication of 
DNA each time a cell divides.  
When the DNA is wrapped as tightly as it is inside the cell, it requires additional proteins to relax 
the supercoiling, knots, and tangles of the DNA16. During replication when helicase unwinds the 
double stranded DNA (dsDNA) and pulls it apart into two single stranded DNA (ssDNA), tension 
builds up in the rest of the unwound dsDNA. This creates supercoils and knots, which makes the 
further movement of helicase impossible. Topoisomerase binds to the twisted and knotted 
dsDNA region periodically to cut and splice it, so the supercoiling can be relaxed. Without this 
relaxing process, the DNA replication would not be possible. 
This relaxation allows the helicase to continue the unwinding and separation of the dsDNA. As 
the helicase unwinds the dsDNA it will create what is called a replication fork (Figure 5).   
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DNA polymerase (a molecular motor) will then bind the newly created ssDNA. The role of the 
DNA polymerase is to add the complementary base to the ssDNA creating a new dsDNA.  DNA 
polymerase can only synthesize new DNA in one direction that is 5’ to 3’ on the template strand. 
This makes it easy for the movement along one of the strands where the complementary base 
will be added continuously to create the new dsDNA (top strand in Figure 5). But for the other 
strand the polymerase will create smaller loop fragments called Okazaki fragments, to add the 
Figure 5: Cartoon depiction of a DNA replication fork where Helicase (gray) proceeds to the left to open 
the base pairs of the dsDNA molecule into two ssDNA. DNA polymerase (black ring) that binds to the 
bottom ssDNA will move towards right (from 3’ to 5’ direction) on the template strand and continuously 
place the complementary bases to form a new dsDNA molecule. But the polymerase that binds to the top 
ssDNA cannot move continuously as it must move towards the replication fork.  Therefore, it must add 
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complementary bases17 (bottom strand in Figure 5). This DNA replication process creates two 
dsDNA from the parental DNA which is needed as a precursor to cell division.  
 
Fighting Cancer with Small Molecules 
The molecules that have mass under 900 Daltons (a unit that is used in Physics and Chemistry to 
measure mass) are generally considered as small molecules18. These molecules can interact with 
DNA on the molecular level, and in some cases rapidly inhibit the replication of the cell through 
binding covalently and noncovalently to the DNA. Covalent binding of molecules to DNA is 
irreversible whereas noncovalent is reversible. Doxo falls into the category of noncovalent 
interactions, where if given 
enough time it will bind to 
the DNA, but it should also 
come off the DNA as well. 
Non-covalent binding falls 
into three major categories 
(Figure 6)19 intercalation, 
single stranded binding, 
and groove binding. 
Recall the ladder analogy of DNA from earlier, intercalation is simply adding a hypothetical board 
between the steps of the ladder to add strength to the ladder hopefully preventing breaking. 
Intercalators have a particular structure where there is a flat planar section of the molecule (the 
Figure 6: Different types of non-covalent interactions of small molecules with 
DNA. Intercalation (left) involves the sliding of a flat planer molecule between 
the bases of the DNA. ssDNA binding (middle) involves the interaction of the 
molecule with the bases when the base pairing is broken. Groove binding (right) 
occurs when the molecule will fit into the major or minor grooves of the DNA. 
Groove BindingIntercalation ssDNA Binding
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board to go in the steps of the ladder) with a bulky side piece. When an intercalator interacts 
with the DNA molecule it has characteristic changes where the DNA will be lengthened and 
strengthened. This intercalation method can act as a block to both the topoisomerase and 
helicase binding and preventing the replication of the DNA. Intercalators have been used for a 
long time as a cancer therapeutic because they act as a roadblock to DNA replication designating 
the cell for death.  
Threading intercalators are special type of intercalators that have bulky side chains on both sides 
of the intercalating flat region similar to a dumbbell. To bind, these threading intercalators must 
thread one of their bulky side chains through the DNA bases. This extends the time for the binding 
and unbinding process, requiring a structural change in DNA20-22. Doxorubicin has been 
categorized as a classical intercalator where it has a flat planer section with a single bulky side 
chain. Typically, classical intercalators bind and unbind the DNA rapidly in the order of micro-
second time scale. But you will see that our experiments show Doxo binding time scales are 
comparable to typical threading intercalators rather than classical intercalators. 
 
Doxorubicin: One of The Most Prominently Used Cancer Therapeutics 
As mentioned earlier Doxorubicin (Doxo) has been stamped with the nicknames of Red Devil1 
and Red Death2 due to the distinctive hue matching that of blood, and the gruesome side effects 
it can cause. Despite this, Doxo and the other drugs part of the anthracycline class, including 
daunorubicin (Daun), epirubicin (Epi), and idarubicin (Ida), are still some of the most prominently 
used cancer drugs today. Up to 32% of breast cancer patients23, 57-70% of elderly lymphoma 
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patients24,25, and 50-60% of childhood cancer survivors are and were treated with the 
anthracycline class of drugs26,27. Over the last several decades, a “better anthracycline drug” has 
been vigorously searched for without tremendous luck.  
Doxo is effective against a plethora of hematopoietic cells (immature cells that can develop into 
the different types of blood cells) and solid tumors, including leukemia, breast cancer, soft tissue 
sarcomas, childhood, sold tumors, lymphoma, along with several others28 with an exception 
being that colon cancer does not respond to Doxo29. Regardless of Doxo’s presence of being a 
cornerstone in anticancer therapeutics there is much more to be understood.  
To halt cancer, it is necessary to cause the cell to undergo apoptosis (killing itself), and this is 
exactly what Doxo can trigger. The manner in which Doxo inhibits cancerous cell reproduction is 
the interaction between Doxo and DNA along with topoisomerase inhibition. Doxo, like other 
anthracyclines is known to intercalate, in which the drug molecule will have a bulky side part 
outside the DNA double helix while its flat-planar aromatic ring system is slid between the base 
pairs30 of the DNA. This in turn increases the stacking forces within the DNA base pairs through 
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electron transfer, holding Doxo in place once intercalated31. The structures of Doxorubicin and 
Doxo intercalated between DNA base pairs of DNA can be seen in Figure 7 32.  
 
This same process inhibits the enzyme topoisomerase II 33, which limits the rotational force of 
the DNA during the replication process34.  
The intercalation process is left largely mystified because while Doxo intercalates it also 
aggregates with itself forming dimers before and while intercalating35-37. This adds a level of 
complexity in understanding the exact mechanisms in which Doxo interacts with DNA. Further 
complicating the interaction it was reported that aside from intercalating, Doxo (positively 
charged in solution) also binds to the major and minor grooves of the DNA31. Furthermore it has 
been reported in some cases that Doxo exhibits preferential binding to particular base pairs of 
the DNA. 33  
a b c
Figure 7: (a) Chemical structure of Doxorubicin  (b) two orientations of 3D structure of Doxorubicin  
showing the flat planer section and bulky side chain more clear and (c) two Doxorubicin molecules 
bound to DNA through intercalation (PDB: 1D12) 
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The Red Devil can rear its head in multiple ways, including cytotoxic side effects, therapy-related 
malignancies, infertility, cardiac, and bleeding through the palms of the hand and soles of the 
feet respectively from palmoplantar disease38. All these negative side effects limit the clinical 
application of the Doxo administration39.   
The detailed binding characteristics of Doxo to DNA has been reported differently throughout 
several published articles, causing intense debate40.  In the millimolar range Doxo will aggregate 
with itself prior to interacting with the DNA41. In some cases reporting that it forms a dimer36,  
and in others it is reported as self-association of 3 to 4 molecules of Doxo35.  In either sense this 
would alter the reports of the behavior in Doxo and explains the intense debate.  
It has also been reported that Doxo first binds to the minor groove of the DNA, then intercalates 
itself between the base pairs40. The only single molecule study, in which Doxo is explored is at 
low forces (under 10pN), its affinity to DNA is reported as 5.3 ± 0.3 x105 M-1, and a binding site 
size of 1.4 ± 0.4 35. In other studies, binding affinity values reported for Doxo binding to the DNA 
ranges from nanomolar (2.3 x 108 M-1) to micromolar (9.3 x 105 M-1)36.  
For a drug that has been used on countless patients since the 1960s there is much left to be 
understood regarding the interaction with DNA. In this study we quantify both the binding affinity 
and binding kinetics of Doxo to DNA at the single molecule level. To our knowledge only one 
previous study has been reported at the single molecule level and was done only at low force 
range using optical tweezers. We use dual-beam optical tweezers which allow us to reach high 
forces past the melting transition of the DNA and the ability to provide complete characterization 
of the drug at the single molecule level for the first time. 
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Introduction to Optical Tweezers 
In 2018 the Nobel Prize was awarded to Dr. 
Arthur Ashkin for the optical tweezers and 
its applications to biological systems42. Dr. 
Ashkin along with Dr. Steven Chu pioneered 
the creation of the optical trap more than 
thirty years ago. Figure 8 shows what the 
first optical tweezer looked like that Dr. 
Ashkin and Dr. Chu were working with, 
notice the abundance of wires and 
additional equipment. In the early seventies, Dr. Ashkin published the theory to use the radiation 
pressure of light, to trap and manipulate small particles that would be invisible to the naked 
eye43. The theory came to fruition in 1986 when Dr. Chu was able to capture and cool atoms44,45, 
which won him the 1997 Nobel Prize in physics for this accomplishment along two other 
scientists, William Phillips and Claude Cohen-Tannoudji. One year after the trapping of atom, Dr. 
Ashkin was able to trap a single virus and bacterium without damaging it in 198744.  The trapping 
of biological materials with lasers have been a challenge because water absorbs the energy from 
the radiation, heating up, and ultimately killing the sample. Dr. Ashkin overcame this challenge 
by using lasers with infrared wavelengths, where the water absorption is at the minimum. In the 
years to come, Dr. Ashkin was able to manipulate single cells46, then organelles47. He even 
Figure 8: Dr. Ashkin (right) working with Dr. Chu (left) in 
1986 at Bell Laboratory in New Jersey, USA, to trap and cool 
atoms using lasers. 
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reported force measurements using the optical tweezers by moving organelles within the cell48. 
This opened up a new method to study biological systems at the single molecule level. 
In 2014, at BSU a president for optical trapping was set by Dr. Deveney and his students by using 
lasers to trap tiny (5 μm) polystyrene beads.  Several years later in 2016, undergraduate students 
with the guidance from Dr. Thaya constructed a dual-beam optical tweezers set-up that can be 
used to conduct single molecule biophysics research. It is believed that this is the first set-up of 
this caliber that is constructed and maintained completely by undergraduate students in the 
Nation. There are roughly thirty of these set-ups across the world that are constructed in a similar 
way. 
 
Understanding the Physics of the Optical Trapping 
To understand the physics of trapping with light we first need to understand force created by 
momentum change during two main phenomena of light, reflection and refraction. 
Imagine an introductory physics problem where there is a truck driving down a road and slams 
into a tree, bouncing off. Now think about the light from a simple laser pointer being pointed off 
a mirror and reflected in a different direction. What is the similarity between the two events? In 
both events the truck and light carry a linear momentum which caused them to bounce off an 
object. It is easy to understand that a truck carries linear momentum (mass  velocity), but it is 
more complex to imagine that light can also have momentum. This can be explained by 
combining quantum mechanics and wave-particle dual nature of light. 
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With that said, Newton gave the equation of 𝐹 =
𝑑𝑝
𝑑𝑡
 , meaning that there is force that is 
represented by the rate of change in momentum. In the previous example the rate of change in 
momentum of a truck is much greater than that of a laser, therefore the force associated with 
the laser is minute. Although we, as humans, may not necessarily feel a force from a photon there 
is a force and pressure applied to a particular location of impact The pressure created by the 
force is proportional to the force: 𝑃 =
𝐹
𝐴
, where F is force, P is pressure, and A is area. Substituting 





. This equation is saying that 
there is a particular pressure associated with the laser reflecting off a mirror, this is deemed the 
radiation pressure.  
Just like the reflection of light can cause change in momentum and in turn result in a force as 
discussed above, another phenomenon of light known as refraction can also result in a 
momentum change and lead to the creation of force. The speed of light changes depending upon 
the medium in which it is propagating through. When light transitions from one medium to 
another it will bend, and this is bending of light known as refraction.  
Snell’s law describes the bending of light at the interface of the two mediums, which states that 
𝑛1𝑠𝑖𝑛𝜗1 = 𝑛2𝑠𝑖𝑛𝜗2, where n1 and n2 are refractive index of the mediums. Mediums are given 
refractive indexes based on the speed of light in that medium. The angles θ1 and θ2 are the angle 
made by the incident beam and refracted beam respectively with the normal.  
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In the case of the optical tweezers, the laser will be passing 
through the liquid buffer medium (with refractive index n1) to 
the polystyrene bead (with refractive index n2) as shown in 
figure 9. Since n2 is greater than n1, the incoming ray (red) will 
be refracted (green) towards the normal according to Snell’s 
law as shown in Figure 9. Some of the laser radiation will also 
be reflected (brown).  
On the way out of the bead it will bend away from the normal. 
The refraction of two symmetric laser rays passing through a 












Figure 9: Application of Snell’s Law as it 
pertains to the optical tweezers. 
Incoming laser radiation (red) from the 
buffer medium, makes impact with the 
surface of the bead where part of it is 
reflected (brown) and the rest is 
refracted (green). 
Figure 10: Schematics of a laser focused by an objective onto a single micron sized point holding a bead in place 
and Ray diagrams explaining the physics. (a)  The case where the bead is along the optical axis of the objective and 
the enlarged view describing the symmetric rays refracting through the bead. The left inset shows the momentum 
changes of both beams (light red arrows) resulting in the net force (black arrow) on photons. The right inset shows 
the equal and opposite force acting on the bead. (b)The case where the bead is entering the laser beam from the 
left and the enlarged view describes an intense ray from the center of the laser bean and less intense ray from the 
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The bending of light while passing through the bead creates the momentum change of the 
photon, and henceforth a force of the photon. From this we can figure out the direction of the 
net force acting on the bead which will be opposite of that on the photon. The resulting force in 
the symmetric case will be in the direction towards the focal point of the objective (Figure 10, 
left). When the bead is misaligned and away from the axis of the laser (Figure 10, right), the 
gaussian nature of the laser will still trap the bead. That is because the middle part of the laser 
emits more intense radiation, therefore it will apply more force on the bead pushing it towards 
the center optical axis.  
Trapping and Stretching DNA with Optical Tweezers 
When the bead that is trapped is pulled out of the trap by a force the laser gets deflected and 
that deflection can be measured using detectors and then converted to force measurements.  
This concept is used to tag biological molecules to the bead to obtain force measurements. Dr. 
Steven Block was able to trap a single DNA molecule and stretch with optical tweezers and 
measure the force experienced by the DNA as function of extension in 1997 49. This results in the 
force-extension curve commonly known as DNA stretching curve (Figure 11). You can see that 
the forces experienced while stretching is in the order of pico-newton (pN), which is 10-12 N and 
is very small and comparable to the forces exerted inside the living cell. This makes optical 
tweezers a great tool to study the force responses of biological materials.  
 











DNA stretching is a reversible process where when it stretched and then given ample time to 
return it should return exactly the way it began. The black line in Figure 11 represent the force 
measured while stretching the DNA and the black broken line represents the release of the DNA.  
At the beginning of the stretching in the bottom left highlighted in light purple in Figure 11 the 
DNA is slack with all the base pairs properly annealed. Not much force is needed to stretch it to 
its natural length to make it taut. When we make the DNA taut, we are reducing its entropy 
therefore this region is referred to as the entropic regime. Once the DNA is taut further pulling 
makes the backbone of the DNA respond by beginning to untwist. This phase of DNA stretching 
can be modeled similar to that of elastic band, or spring, where the DNA is fighting to be 
Figure 11: DNA stretch (black circles – black solid line) and release (black dashed line) curve with 
the four important regions highlighted. Entropic Regime (purple), Elastic Regime (blue), 
overstretching transition (green), and ssDNA (yellow). When enough time is not given the DNA 
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stretched50. This second region highlighted blue in Figure 11 is known as the elastic regime. In 
the elastic regime there is little extension seen but a large increase in force response from DNA 
which increases from near zero to 65 pN. After reaching 65 pN you can see that the DNA length 
is almost doubled without much change in the force. This region shaded green in Figure 11 is 
labeled as the overstretching transition. There have been multiple models that has been debated 
over the year on what’s happening to the DNA in this region51,52. After almost twenty years have 
passed since the first DNA stretch, now many agree that the DNA base pairs begin to break and 
that causes the greater extension of the DNA without much of an increase from the 65 pN force. 
This is referred to as Force Induced Melting (FIM). The DNA goes through a phase transition from 
dsDNA to mostly ssDNA at constant force, similar to ice melting into water at constant 
temperature. The last regime (highlighted light orange in Figure 11) is the ssDNA regime where 
most of the bases of the DNA are broken except regions of the DNA that are GC rich. Upon release 
of the DNA from the ssDNA regime the bases begin to reanneal. Occasionally the DNA will not 
properly anneal resulting in the hysteresis seen in Figure 11 indicated by the red arrow. Figure 12 
depicts a cartoon describing the state of the DNA in each regime of the DNA stretching curve.  
 










Studying Intercalation using the Optical Tweezers 
Understanding how the DNA stretching curve changes when the DNA is stretched in the presence 
of an intercalator provides insight into the binding mechanisms and strength of binding. Models 
hence have been developed which quantify these interactions between the DNA and these 
molecules53. Obviously when intercalators insert their flat parts between the DNA base pairs, the 
DNA will have a corresponding lengthening. This DNA lengthening can be seen in the DNA 
stretching curves as indicated by the blue arrows in Figure 13.  
 
 
Figure 12: A cartoon representation of what the DNA could look like in each regime of the DNA 
stretching process. In entropic regime DNA is in its natural state, bundled and slack. In the elastic 
regime the DNA begins acting like a spring resisting stretching. Overstretching transition, the 
base pairs begin the melt except for regions that are rich in GC content. In the ssDNA regime 
most of the base pairs are broken apart. Upon the relaxation the DNA begins to reanneal back to 


















Imagine you have two glass sheets stacked on top of each other, it is relatively easy to pull the 
two apart from one another. Now, add water, that task becomes a lot more difficult than the 
previous attempt. The premise is the same with an intercalator when it is added to DNA. Initially 
it is easy to pull the DNA apart but when an intercalator is added the task gets more difficult.  
As the intercalator inserts itself into the DNA it is increasing the pi-pi bonding between the base 
pairs strengthening the DNA. In experiments this is seen through needing an increase in the force 
needed to melt the DNA during the overstretching region (Figure 13)18.  
Both of these effects, the lengthening of the DNA and increase in the melting force, increases as 
we add more intercalators. This is clearly visible in Figure 14 54 where DNA is stretched  in the 





















Increase in Melting Force
DNA Lengthening 
Figure 13: DNA stretching curve in the absence (black) and in the presence of an intercalator 
(red). Highlighting the associated increase in length (blue arrows) and increase in force 
required to melt the DNA (green arrows) in the presence of intercalator. 
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certain a critical concentration (125 nm in this example) the melting transition disappears 
indicating the impossible nature of melting the dsDNA in the presence of intercalator. 
Figure 14: DNA stretching in the presence of various concentrations of a well-
known classical intercalator, Ethidium Bromide (colored curves) and in the 
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Materials and Methods 
Preparation of Biomaterials 
In our experiments we use four main biomaterials: buffer solution, polystyrene beads, DNA, and 
the drug under investigation (in our case Doxo). All of which requires the buffer solution for 
preparation. Our buffer imitates that of the physiological conditions seen inside the body, which 
has a pH of 7.4 and a salt concentration of around 150 mM. The buffer solution we prepare is 
done so by combining 5.885 g of NaCl, with 10 ml of 10 mM Tris, and 990 ml of Milli-Q water 
(special water that has gone through a series of deionization and filtration steps to maintain a 
resistivity of 18.2 MΩ cm). The buffer is then filtered and tested to have a pH of 8, slightly more 
basic than physiological conditions along with a salt concentration of 100 mM which is slightly 
lower than the physiological condition. 
The biosafe beads that we use in our experiments are bought from Spherotech. They are 3.11 μm 
diameter polystyrene beads that are coated with streptavidin (SVP-30-5). 
The lambda phage DNA (48,500 bp) used in 
our experiments are purchased from Sigma-
Aldrich and labeled with biotin on the 5’ 
ends in the lab. This labeling enables the 
tethering of DNA to the beads by forming 
streptavidin-biotin complex (Figure 15) when 
introduced into the system.  
Figure 15: Cartoon showing the binding mechanism of 
streptavidin and biotin that allows the biotin labeled DNA in 
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Doxo was bought as a powder from Fisher Scientific (AAJ64000MA) and a stock solution of 
11.49 mM was made by adding 10 ml buffer. By taking 4.35 μL from the stock and mixing with 
495.65 μL a sub-stock solution of 100 μM.  Before every experiment was carried out the sub-
stock eppendorf tube was vortexed well to assure the solution was properly suspended. This was 
done because the drug could have been sitting for a long period of time in between experiment, 
and because we read that the drug can aggregate in the millimolar range. Although that is far 
away from our micromolar range we did so out of precaution. The concentration of the drug was 
also occasionally double checked with absorption spectroscopy. For each experiment, the exact 
concentration of Doxo needed was calculated by hand and then assured using a calculator built 
into our data analyzation program. The solution was then made in the reservoir tube and ready 
to be used in the experiment once mixed.  
The buffer is stored in a sterile 1 L plastic container at room temperature while the rest of the 
biomaterials are stored in a temperature-controlled refrigerator at 4°C. Upon need of a particular 
biomaterial, it was removed from the refrigerator prepared, pipetted in the respective reservoir 
tube and then immediately placed back into the refrigerator for preservation. 
 
Dual-beam Optical Tweezer Set-up in the Single Molecule Biophysics Lab 
The SMB Lab, where the optical tweezer set-up is kept, is in a temperature-controlled room at 
25°C. The entire set-up is built on an optical table that roughly weighs 800 pounds which sits on 
four cylinders that are supplied with air from an external compressor. This air then causes the 
table to rise and float allowing for the system to be isolated from vibrations in the environment. 
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Since the forces measured in our experiments are in the order of pico-newtons any vibrations 
that come from walking down the hallway, or to doors slamming in the building will have to be 
isolated and the optical table does this job. Any vibrations or changes in temperature will also 
alter the laser alignment, which is exceedingly difficult to obtain in the first place. An image of 









In our dual-beam optical tweezer, a single beam from laser gets split up into two separate 
pathways and then gets finely focused onto a single micron sized point. A micron sized point is 
equal to one-hundredth of the thickness of a single piece of your hair. The reason for the dual-
beam optical set-up opposed to a single beam apparatus allows for us to reach higher forces. 
Figure 17 represents a bird’s eye view of the details and components involved in making the 
functional dual beam optical tweezers at BSU.  
Figure 16: The dual beam optical tweezer set-up at BSU. The laser which is not actually visible is 
depicted here with red line to visualize the laser beam path. 
 










We use a single butterfly laser diode to produce a beam that is just out of the visible spectrum of 
light and in the inferred spectrum. A full component break down of the components of our table 
can be found in55. The 275 mW beam, linearly polarized to be vertical to the table exits through 
the fiber port, travels to the right on the diagram to the first beam splitting cube where the single 
beam now becomes two with equal power. Each beam then encounters a series of mirrors to 
reach the polarizing beam splitting cubes (shaded in green) at the bottom of Figure 18Figure 17. 
Disregard the blue lines on the edges of Figure 17 for the moment and continue to follow the red 
laser line on the left.   
The polarizing beam splitting cube is designed in a manner to split an un-polarized laser into two 































































Figure 17: Schematic of the dual beam optical tweezer set-up and the components used at BSU 
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beam such that the plane is vertical (Figure 18)55, polarized vertically, and the transmitted laser 
will be polarized horizontally.  
In our set-up the green colored polarizing cube 
is used primarily to steer the vertically 
polarized laser in the direction of the objective 
through reflection. The second polarizing beam 
splitting cube (color coded in blue in Figure 17) 
is placed in an orientation such that the 
vertically polarized beam will be transmitted 
and any horizontally polarized light to be 
reflected directly up towards the director. 
Therefore, our vertically polarized beam from the left will be transmitted through the cube to 
reach the quarter wave plate. 
The quarter wave plate will alter the polarization of the beam making it circular before entering 
the objective. The objective then focusses the laser inside a microfluidic flow chamber that we 
call the flow-cell, where we trap the beads and the DNA to conduct our experiments. The 
objectives used in our set-up have 60x magnification with a working distance of 2 mm and a 
numerical aperture of 1.2. Numeral aperture is measure of how the light is bent while focusing 
the laser and depends on the refractive index of the medium. Higher numerical aperture will 
result in a stronger trap. 
Figure 18: The beam splitting polarizing cube reflects  
the vertical polarization that is parallel to its 
reflecting plane (green) and transmits the horizontal 
polarization (yellow) through the cube. 
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When the laser passes through the trapped polystyrene bead and emerges out from the opposite 
objective it will pass through the other quarter wave plate (on the right) making the laser linearly 
polarized again but with a 90° rotation. This means that after the laser passes through both 
quarter wave plates (through the objectives) it will be horizontally polarized.  
As the horizontally polarized laser then encounters the polarizing beam splitting cube on the right 
side of the objective (color coded blue in Figure 17) it will be reflected towards the diode detector. 
A lens with a particular focal length and an intensity filter prior is used to focus the laser into the 
diode detector and protect the diode from high intensity. This diode detector measures the 
deflection of the laser and from that we can extrapolate the corresponding forces.  
Now consider the blue line that represents the light that comes from the blue LED on the left 
side. This provide collimated light to the objectives to illuminate the flow-cell, which will be 
discussed shortly. This light then is directed to the opposite camera to provide the image inside 
the flow-cell. All the optical components discussed above will not have any effect on the blue 
light because of its random polarization.  
An achromatic lens prior to the camera is used to focus the image and a particular bandpass filter 
is used exclude the unwanted light entering the camera. This unwanted light would distort and 
take the image impossible to see. These cameras are projected into a computer screen that allow 
for us to visualize and manipulate the experiment.  
The laser beam and blue light travelling in the opposite direction will follow a similar path as 
described above for the beam travelling from left to right. 
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The Flow-cell 
Our entire experiment is conducted in what is called a flow-cell which can be seen in Figure 19. 
These flow-cells are hand constructed at BSU where we get the plexiglass spacer from the 
machine shop with three holes drilled in it (the micropipette tip hole, waste tube hole, and a hole 
for the four inlet tubes) and a hollow channel in the middle. The flow-cell is then cleaned using 
dish soap and dried, then further cleaned using methanol. This is done rigorously to remove any 








An optical adhesive (NOA68, 6801, Norland Products) is added to one side of the plexiglass spacer 
evenly and microscope cover glass slide (22 x 30 x 0.13 mm, 12-545A, Fisher Scientific) is then 
placed precisely and carefully on the adhesive. Its then exposed to UV light for 45 minutes to cure 
the glass slide to the plexiglass spacer. This process is repeated for the other side to obtain a 
chamber.  
Figure 19: A hand-constructed plexiglass flow-cell with four inlet tubing (left) that 
allows to the flow the biomaterials, a waste tubing (right) which collects the liquid 
waste from the experiment and micropipette tip (top) inserted into the flow-cell 
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A borosilicate glass micropipette tip (TIP1TW1, World 
Precision Instruments) is then inserted through the top 
vertical channel. Inserting this glass tip takes precision 
and requires the use of a microscope with 100x 
magnification to slowly move the tip down the channel 
hole. Any bumping of the tip on the side of the channel 
will cause the single micron sized tip to crack, ruining 
the entire flow-cell causing a restart of the process. 
Figure 20 shows the image of the tip under the 100x microscope. The micropipette glass tip is 
adjusted until it is placed directly in the center of the main flow chamber. Once perfectly placed 
a dab of the optical adhesive is used and exposed to the UV light for 45 more minutes to secure 
the tip in place.  
After the curing process a diamond tipped pen is used to break the excess of the micropipette tip 
leaving only a single centimeter exposed. A 7-inch long piece of Tygon® Microbore tubing, with 
inner diameter of 0.020” and an outer diameter of 0.060” (EW-06419-01, Cole-Parmer), is used 
to fit directly around the micropipette end. It is then sealed with optical adhesive using the same 
procedure as before.  
Next the four BD Intramedic Polyethylene tubing (PE10, VWR) are inserted to one of the sides of 
the flow-cell to be used as inlets. These four tubes are cut to be about 8 inches long and have an 
inner diameter of 0.011” and an outer diameter of 0.024”. Once placed through the hole into the 
flow-cell chamber it is important to carefully maneuver the tubes to the edge of the hole not 
having too much of the tubing inside the chamber. Having too much tubing inside the chamber 
Figure 20: The micropipette tip inside the flow 
channel viewed under a 100x microscope.  
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or not aligned with the edge of the drilled hole will cause turbulent flow of the biomaterials. The 
optical adhesive and UV light procedure is once again carried out once the tubing is placed 
properly. The reason to have four inlet tubes is for the four types of biomaterials needed to carry 
out the experiment. Buffer, polystyrene beads, Λ-DNA, and the drug of interest that is being 
studied. 
Finally, nearly a 12” long BD Intramedic Polyethylene tubing with a inner diameter of 0.045” and 
an outer diameter of 0.062” (PE 160, VWR) is inserted into the third hole of the flow-cell to serve 
as the outlet tube (waste tube). Similar to the four inlet tubes the waste tube needs to be places 
perfectly in the remaining side hole to the flow-cell chamber. Once placed, again the adhesive 
and UV light combination are used to seal. The flow-cell is now ready for experiments. The 
replacement of the flow-cell is required only when the drug in the chamber and cannot be 
completely washed away with buffer and a molecular cleaner, Tween, (this commonly happens 
at high concentrations of Doxo) or when the flow cell leaks.  
 
Biomaterial Reservoirs and the Flow Control Process  
The biomaterial reservoirs are used to feed the flow-cell the needed biomaterial through its inlets 
during the experiments. These reservoirs are designed with 15 ml tubes with a custom drilled 
hole in the bottom of them (the holes are drilled in the machine shop).  
The same type of tubing that is used for the waste tube of the flow-cell is used as the outlet of 
the reservoirs. A 9” piece is placed inside the hole and sealed using the optical adhesive and UV 
light to cure. Each of the four reservoirs are then placed in a special designed biomaterial 
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reservoir holder to hold each one independently. 
This is a custom-built reservoir holder designed by 
SMBL lab members in 2017. Each tubing is then 
placed through separate clamp gates (circled in 
yellow in Figure 21).  In addition to allow the flow 
the clamps are used to prevent backflow into the 
reservoirs when they are not in use.  
The way we are able to flow the desired fluid at a 
particular time is due to the fact of compressed air. 
Each reservoir has a cap that is attached to a tubing 
(circled red in Figure 21) and connected to a 
solenoid valve. The solenoid valves are connected 
to the compressed air system and controlled by a 
custom-built electrical flow control box (built by me 
in 2018).  With a flip of a switch from the electrical 
flow control box (Figure 22) it is possible to flow the 
desired fluid into the flow-cell. When the desired 
switch is flipped on the flow control box it will causes 
a solenoid to displace allowing air to flow through 
the valve into the tubing that is connected to the cap 
of the reservoir. This air pressure will push the 
biomaterial in the reservoir into the flow-cell.  
Figure 21: The clamps (circled in yellow) that 
serves at gate for biomaterial flow from the 
reservoir. The tubing attached to the caps of the 
reservoir tubes (circled in red) connects to 
compressed air flow. 
Figure 22: Custom designed flow control box to 
flow our four biomaterials. Upon flipping of a 
single switch, it will induce the solenoid (not 
shown) to move a magnetic clamp allowing for 
compressed air to flow through the tubing to 
the reservoir holders at adjustable pressure. 
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Connecting the Flow-cell to the Biomaterial Reservoirs and cleaning 
Once the flow-cells and the biomaterial reservoirs are completed they should be connected, and 
a series of tasks must be completed prior to the start of an experiment. The edges of the tubing 
to the four inlet tubes are trimmed diagonally to assure that we do not get any dust or other 
contaminants into our system. This freshly cut tubing is then connected to the tubing that comes 
out of the reservoir tubes as shown in Figure 23. The waste tube is connected to the waste 







The new flow-cell that is attached to the biomaterial reservoir system is flushed with two 
milliliters of buffer from each of the four different reservoir tubes independently. This flushing 
with buffer accomplishes cleaning the system of any dust particles or unseen contaminants. Once 
the flow-cell is flushed then a little bit of buffer is added in all four reservoirs and flowed through 
the tubing. But this time the purpose is to fill the system with buffer such that there are no air 
pockets or bubbles in the system.  
Figure 23: The flow cell inlets connected to reservoir tubing (circled in yellow), the waste tubing 
connected with waste connected with waste container and micropipette tubing connected 
with the syringe. 
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Are we ready for the experiment yet? 
Now that the flow-cell has been properly hooked up the 
reservoirs, washed out and filled with buffer we are now ready 
to place the flow-cell between the microscopic objectives. The 
flow-cell is placed on a moving stage that can be manipulated 
by hand and piezoelectric controller. This must be accomplished 
using steady hands, and precision without scratching the 
objectives. As seen in Error! Reference source not found. the 
stage clips (yellow arrows) are separated to wedge in the flow-
cell between them and the whole flow-cell is then slid down into 
the clamps.  
The reason for such diligent work is that if the objectives are 
bumped or displaced the alignment of the laser will have to be 
redone which can take hours to up to weeks to fix. The stage 
(Figure 24) allows for manual movement of the stage in three 
dimensions along with fine nanometer movements in one 
direction. A piezoelectric crystal within the stage that expands 
or contracts with applied voltage allows for the fine movement 
of the stage in one direction. During experiments this is 
controlled by the computer program to move the stage to 
Figure 24: The stage (front) that is 
used to mount the flow-cell. The two 
shorter length knobs (coming 
towards the front and left) are for 
manual control and the longer knob 
coming towards the front can be 
manipulated both manually and by 
the computer. 
Figure 25:The flow-cell dock and 
clips that hold the flow cell in place 
mounted in the piezoelectric stage. 
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stretch the DNA. Now that we have the flow-cell docked on the piezoelectric controlled stage, 
we are ready for the real action. 
Lights, Camera, Action 
Before turning on the laser we need to understand the 
operation conditions of the laser. The laser selected for 
the optical tweezers contains particular characteristics 
necessary for the functioning of the experimental set-up. 
The laser used in the BSU SMB lab is a butterfly diode laser 
that is housed in a compact LD and temperature controller 
as seen in the Figure 26. The controller is hypersensitive 
to electrical surge so before touching it is of up most 
importance that the researcher grounds themselves before turning on the controller. As the laser 
controller boots up to the screen seen in the figure 26, the internal temperature is set to its 
operational temperature of 25°C. Once the temperature reaches this value, the laser warning 
sign at the entrance of the lab is turned on for safety, and then the laser is turned on. The laser 
has a power of 250 mW and a wavelength of 785 nm which is just outside the visible spectrum 
towards inferred. The laser transmits through all the optical elements as discussed earlier in the 
optical tweezers set up.   
To see the image of the flow-cell while the experiment is happening, we use blue LEDs on both 
sides of table (as we discussed earlier, Figure 17). These blue LEDs are used to illuminate the flow-
cell allowing for an image to be created in the camera. There is an adjustable setting on the blue 
Figure 26: Laser controller that houses the 
laser that is used for the optical tweezers. 
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light that allow us for the brightness to be adjusted as needed. These cameras are connected to 
a computer above the optical tweezers dedicated to process the camera image. Through a 
program we can select which camera we would want to see on at a specific time. Throughout the 
experiment we shuffle back and forth from one camera to the other. 
 
The Game Plan 
 The overall idea of the experiment is to trap a bead with laser and attach it to the micropipette 
and trap another bead to be held by the laser. After trapping the beads, DNA is flown through 
the flow-cell and a single DNA molecule is chemically attached between the two beads. The DNA 
is stretched to check if it is a good candidate for experiments. If it is good DNA the drug is added 
to the system and then the DNA is stretched in the presence of the drug. Figure 27illustrates the 
main steps of the experiments, which will be discussed in detail in the coming sections. 
Figure 27: Process of catching a single molecule of DNA inside a flow cell with optical tweezers. (a) Polystyrene 
bead caught in laser trap. (b) First bead attached to micropipette tip and second bead is captured in the laser 
trap. (c) DNA is introduced into the system and one end is attached to the bead in the trap. (d) Other end of the 
DNA is attached to the bead on the micropipette tip and drug introduced into system. 
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Trapping Bead and Checking the Laser Alignment: Obtaining a Stiffness Curve 
The first step of our experiment is to check the strength of our trap and fine alignment. This is 
done by trapping a bead and obtaining a curve called stiffness curve.  
The bead reservoir is filled with 2 ml of buffer and 2 μl of 3.11 μm polystyrene beads coated with 
streptavidin is added and vigorously mixed so that the beads are equally distributed throughout 
the reservoir tube. The beads flow is turned on until a bead is trapped. 
The trapped bead is then attached to the 
micropipette tip via suction using the 
syringe and the rest of the system flushed 
of stray beads. The bead on the 
micropipette tip is moved across the laser 
spot using the computer program to 
obtain the trap-stiffness curve (figure 28). 
In the trap-stiffness curve although the y-
axis is marked “force” and the x-axis is 
marked “position”, you will see that the 
units of the force is marked as microns. 
The reason behind this is the program is essentially plotting the deflection of the laser beam due 
to the bead moving into the trap. The reason we see two different plots (blue and green) on the 
graph is because we have two diode detectors on either side (refer to Figure 17). The solid circle 
Figure 28: Screenshot of our program showing a stiffness 
curve obtained prior to an experiment. The blue and green 
dots represent the deflection of the laser as the bead passes 
through the laser spot by the detectors on either side. 
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represents the micropipette tip moving away from the origin initiated while the open circle 
represent the return. If the alignment is perfect, both plots should overlap and most importantly 
both curves should have the same slope. If they do not overlap, fine laser alignment is needed 
and carried out by adjusting the fine adjustment controls for the piezoelectric stage.  
Once we have the alignment done, we move the bead attached to the pipette away from the 
laser spot and trap another bead with the laser. The system is then flushed of the stray beads 
with the buffer. Now we have two beads one attached to the pipette and the other trapped and 
held by laser. We are ready to catch a single DNA molecule. 
 
Let’s Go Fishing: Catching a Single DNA Molecule 
The DNA reservoir is filled with nearly 2 ml of buffer and 2μl of the biotin labeled Λ-DNA (48,500 
base pairs) is added. One may think that adding more DNA will enable the DNA trapping process 
to be easier but having too much DNA in the reservoir will cause havoc in the system. The DNA 
will aggregate with each other, stick the flow-cell, and saturate the experiment rendering it 
useless. Therefore, it is important to find the right balance between having enough vs having too 
much. It is important to be very gentle with the DNA unlike the beads. The DNA should be mixed 
slowly with the 1 ml pipette assuring no bubbles are put into the reservoir tube.  
Using the manual controls for the piezoelectric stage we moved the bead attached to the 
micropipette tip about 6 μm away from the one in the trap. Then the DNA is flowed into the 
system, allowing it to bind to the bead in the trap. Once one end of a DNA is attached to the bead 
in the trap the free end will be floating with the flow. By preforming a series of circular 
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movements, we can attach the floating end of the DNA to the bead attached to the tip.  Resulting 
in a single DNA molecule between the two beads (Figure 29).  Once a single DNA molecule is 
trapped the stray DNA is rinsed by flowing buffer through the flow-cells. We are now ready to 
stretch the DNA. 
 
Playing Tug-of-War with DNA 
The parameters on our computer program that controls the data collection are then set to take 
100 nm steps and wait for 75 ms after each step to collect 1000 data points from the diode 
detector at each step. Based on the initial point the total number of steps is also given to the 
program so that the DNA can stretch through the entire melting transition.  As the bead on the 
micropipette tip is moved away from the trap (to the left in Figure 29), the bead in the trap will 
slightly move (to the left) as well indicating there is a DNA molecule between the two. In real 
experiments we won’t be able to see the DNA but I have drawn a cartoon DNA in Figure 29 to 
make it easy to visualize. As the bead in the trap shifts due to being pulled by the DNA, the laser 
deflection is measured by the diode sensors. The stretching curve produced is checked with the 
Figure 29: A cartoon DNA (blue) drawn on top of the actual image seen during experiments.  
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standard DNA stretching curve (shown in the introduction, Figure 11). If it does not match that 
means it is not a good piece of DNA, thus unusable for an experiment. In the unusable case, the 
system would then be flushed with buffer and air from the syringe. We then would then start the 
experiment from scratch beginning with placing the flow-cell into the stage clips. We analyze this 
curve based upon two models: worm like chain and freely jointed chain model that are discussed 
in appendix 2.  
 
Stretch and Release Experiments with DOXO 
Once we have a good single DNA molecule attached between the beads, we are ready for our 
real experiments. The concentration of Doxo is made to make a 2 ml solution with buffer within 
the drug reservoir. Then 1 ml of this drug solution was allowed to flow through the flow-cell 
before the flow was turned off. This was to assure that the flow-cell chamber was filled with our 
desired concentration of Doxo. The DNA is then stretched and released by keeping the same 
parameters used to stretch the DNA without drug (100 nm step size with a 75 ms wait time at 
each step, averaging a 1000 data points at each point). This procedure was repeated at several 
concentrations and at least 3 times for each concentration of Doxo to check the reproducibility 
(shown in the results section). From the literature study, we believed that Doxo should behave 
as a classical intercalator, that means it would bind and unbind to the DNA in microsecond time 
scale. If true, the stretching and releasing of the DNA in the presence of Doxo should have 
overlapped each other, meaning it is in equilibrium, and we should not see any type of hysteresis. 
But to our surprise we saw hysteresis which became even more prominent as the Doxo 
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concentration was increased (data shown in Results section).The fact that the stretch and release 
curves do not overlap can be attributed to Doxo needing an extended period of time to bind and 
unbind the DNA. To test this hypothesis, we switched to a technique called constant force 
experiments. 
 
Constant Force Experiments 
Constant force experiments is a type of experiment that is designed to stretch and hold the DNA 
at a constant force while allowing the drug binding to reaching an equilibrium. Initially the DNA 
is stretched quickly until it reaches the desired force that the user inputs into the program. As 
the drug binds to the DNA, it obviously will extend the DNA and cause a slack which in turn creates 
a slight drop in force. In the constant force experiment the program is designed to counter act 
this decrease in force by stretching the DNA further. The program is created using a force 
feedback loop capable of holding the DNA to the desired force with the precision of 1 pN (this 
value is deemed force threshold and can be changed). This allows for us to collect data that 
describes the extension of the DNA as a function of time in the presence of Doxo at the desired 
force (data shown in Results section). These experiments unlike the stretch and release would 
take up to 30 minutes to complete. Apart from the parameters discussed already (step size, step 
time, and desired force) we additionally could enter in number of iterations desired. The number 
of iterations corresponds to how many steps will be taken at the desired force to reach 
equilibrium, ultimately determining the length of time the experiment took.  Unlike the stretch 
and release experiments Doxo would be continuously flown at a steady rate until the Doxo-DNA 
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complex reached equilibrium. After we see that the drug-DNA binding has reached equilibrium 
the drug flow is stopped, and the buffer is flown. This will wash away the drug from the system. 
Constant Force experiments allows us to quantify the binding kinetics of Doxo to DNA in addition 
to their binding affinity. 
 
Safety 
There was a great deal of training required to before conducting experiments. Proper laser safety, 
chemical safety, and hazard management trainings were paramount. As a lab member I had to 
take a short course and pass a safety exam yearly to fulfill the requirements of BSU and 
Northeastern University.  
When working with Doxo safety is paramount. Anti-cancer drugs also affect healthy cells, so any 
time the drug was in use surgical gloves were used. Streptavidin on the beads, Λ-DNA, and biotin 
is a vitamin, are labeled as non-hazardous chemicals on SDS data sheets, but again surgical gloves 
were used at all times handling chemicals to form good habits. 
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Results 
 
Binding of Doxorubicin in Stretch and Release Experiments 
As discussed in the methods section, at the beginning of the project stretch and release 
experiments were completed for various concentrations between 0.07 nM and 15 nM of Doxo. 
At each concentration, the experiment was repeated multiple times, each time with a new single 
DNA molecule. Figure 30a shows the stretch (purple solid curves) and release (purple broken 
curves) from multiple DNA molecules in the presence of 0.7 nM Doxo is plotted onto a single 
graph. The DNA stretch and release in the absence of Doxo is represented by the black solid and 












0.3 0.35 0.4 0.45 0.5 0.55

























Time (s) Time (s)
a b
Figure 30: The DNA stretch (solid black curve) and release (broken black curve) is used as reference to compare 
the stretch (solid purple curve) and release (broken purple curve) curves of DNA molecules in the presence of 0.7 
nM Doxo. (a) represents multiple DNA molecules in the presence of Doxo mostly overlapping on top of each other 
and (b) the average of those DNA molecules, both showing lengthening of DNA and slight increase in the melting 
transition in the presence of Doxo. 
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molecules shown in Figure 30a looked pretty similar and almost overlaying on top of each other. 
Therefore, we averaged them to obtain a single extension vs. time graphs for the 0.7 nM Doxo 
concentration, which is shown in Figure 30b.  
As expected with classical intercalators, in Figure 30 we clearly see that the DNA is extended upon 
binding to Doxo and a slight increase in melting force during the stretch. But the stretch and 
release curves of the DNA in the presence of Doxo clearly do not overlap. As discussed previously, 
in the introduction and in the methods, the stretching of DNA is a reversible process where it 
should reanneal on the return.  When in the presence of a classical intercalator, the DNA-drug 
complex should equilibrate in the microsecond time scale, thus it should also have overlapping 
stretch and release curves. The fact that this is not the case means Doxo requires more time to 
bind completely to the DNA. This behavior is unconventional for a classical intercalators and since 
almost all literature cites Doxo as classical intercalator we were stumbled upon our first results.  
An identical procedure was repeated with 7 nM concentration of Doxo to see whether our results 
at 0.7 nM make sense. Figure 31 shows the averaged stretch (solid blue) and release (broken 
blue) curves of multiple experiments where a single DNA molecule was in the presence of 7 nM 
Doxo. Now we clearly see a huge hysteresis. Also, the lengthening of DNA during the stretch with 
7 nM Doxo did not change much from the values we obtained for 0.7 nM Doxo. If Doxo did bind 
fast to DNA while stretching, with 10-fold higher concentration we should see clear increase in 
lengthening. But the extensions observed during the return with 7 nM Doxo was definitely 
greater than that obtained with 0.7 nM Doxo. This supported our previous hypothesis that Doxo 
needs more time to bind the DNA.  
 










Additionally, in both cases (0.7 nM and 7 nm Doxo concentrations) as the DNA was stretched 
through the melting transition in the presence of Doxo it resulted in a greater extension of the 
DNA upon return (represented by the purple and blue dashed lines in Figure 30b and Figure 31  
respectively). This added another piece to the puzzle, whether it means that the DNA needed to 
melt to get adequate binding of Doxo to DNA, to reach the equilibrium state. Classical 
Intercalators do not require the melting of the base pairs in DNA to bind typically, this made our 
results go against a well believed trend for a drug that has been studied since the 1970s. We 
continued the same experiments at various concentrations above and below our initial 0.7 nM 



















Figure 31: DNA stretch and release curves in the absence of drug (black) and in the presence of 
7 nM Doxo (blue) showing increase in the melting transition and clear extension of DNA-Doxo 
complex during the release. The blue curve is an average of 5 different DNA molecules. 
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The plot of release curve averages obtained at various concentrations (figure 32) exhibited 
classical intercalator behavior. Both the lengthening and melting force of the DNA increased with 
Doxo concentration. But the main difference being we observe this in the release curves not in 
the stretching curves as observed for all other classical intercalators 53,54,56. As mentioned earlier, 
it can be two factors that cause this. It can be either Doxo is binding slow or it needs the DNA to 
melt to bind. To explore these features further we switched our experiments from the stretch 










Constant force experiments 
Through constant force experiments we can stretch the DNA and hold at a constant force (less 
than the melting force) allowing the drug to reach an equilibrium without going through the 
























Figure 32: : The average release curves of several concentrations of Doxo (dashed colored) with 
the DNA stretch and release curves (black) not in the presence of drug used as reference. 
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the DNA upon the binding of the drug. The DNA-drug complex should then increase in length 
reaching an equilibrium. The final length of the DNA-drug complex is referred to as equilibrium 
extension (𝐿𝑒𝑞).  
Constant force data obtained in the presence of 27 nM Doxo being held at 20 pN is shown in 
Figure 33a.  In these experiments the normal stretch and release curve of the DNA molecule in 
the absence of the drug (black) is obtained first and then the DNA is stretched to the desired 
force and the drug is introduced to the system. The extension of the DNA as the drug binds 
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Figure 33: Constant force measurements at 20 pN in the presence of 27 nM Doxo (a) DNA stretching 
curve (black) in the absence of Doxo and the extension of the DNA that is being held at 20 pN constant 
force while flowing 27 nM Doxo (orange). (b) the same DNA extension upon the binding of Doxo 
plotted as a function of time (c) the force measurement while the DNA is being held indicates how well 
it is maintained as a constant over the duration of the experiment 
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During the data collection the force and extension are recorded as function of time. Figure 33b 
illustrates the plot of extension as a function of time, which clearly shows the DNA elongating, 
reaching an equilibrium extension. The plot of force vs time (Figure 33c) assures a constant force 
(19.9 ± 0.4 pN) was maintained throughout the experiment.  
The extension of the DNA-Doxo complex as a function of time (Data shown in Figure 34) can be 
fit to the following equation:  
 𝐿(𝑡) = 𝐿0 + 𝐿𝑒𝑞(1 − 𝑒
−𝑘𝑡𝑜𝑡𝑡)  (1) 
Where 𝐿0 refers to the contour length of the DNA without the drug, 𝐿𝑒𝑞 is the equilibrium 
extension of the DNA-Doxo complex, and 𝑘𝑡𝑜𝑡 is the total binding rate of Doxo to the DNA. 
Contour length of DNA refers to the length of the DNA molecule at the particular external 
stretching force applied. This value can be obtained from the worm like chain model, the 
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Figure 34: The DNA extension upon binding to Doxo while held at constant force 20 pN in the presence 
of 27 nM Doxo (open circles) the theoretical fit (solid curve) corresponding to the equation (1) 
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The theoretical fit (solid line in Figure 34) for the data (open circles in Figure 34) was obtained 
based on the equation above by changing two fitting parameters, 𝐿𝑒𝑞 and 𝑘𝑡𝑜𝑡. The fitting 
parameters are automatically varied to minimize the sum of chi-squares using the built-in solver 








Where, 𝛿𝐿  is the uncertainty in the measurement of extension.  
This procedure was repeated with multiple DNA molecules (5-6) at 20 pN constant force in the 
presence of 27 nM Doxo to then obtain an average value for 𝐿𝑒𝑞 and 𝑘𝑡𝑜𝑡.  The standard deviation 
of the data was recorded as the uncertainty of the measurement.   
The overall procedure was repeated at several concentrations at four different constant forces, 
20 pN, 30 pN, 40 pN and 50 pN representing the elastic regime of the DNA. Representative data 
and fittings at several concentrations at these 4 forces are shown in Figure 35. 
As seen in the extension vs time plots at all four forces (Figure 35), as the concentration of Doxo 
is increased the equilibrium extension of the DNA-Doxo complex also increases.  Ideally these 
values of equilibrium extensions obtained from the fitting in the constant force experiments 
should match that of the release extensions obtained from the stretch and release experiments.  
Fortunately, in most cases they do match within the uncertainty, indicating that the release 
curves were close to equilibrium. Appendix 3 compares the extensions obtained in constant force 
 
Results | 58 
measurements and release extensions obtained from stretch and release experiments. The 
equilibrium extensions obtained in the constant force measurements are used to determine the 

























































































































Figure 35: Representative data for the DNA extension as a function of time under the various 
concentrations of Doxo at the four different constant forces studied. The open circles represent the 
experimental data averaged while the solid line represents the fit corresponding to equation (1). 
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Binding Affinity of Doxo 
The strength in which a drug binds with the DNA is defined as its binding affinity. In biophysics 
and biochemistry, the binding affinity is commonly expressed in terms of dissociation constant, 
𝐾𝑑, which is the inverse of binding affinity.  
To find the dissociation constant first we find the fractional binding of a drug at a certain 
concentration at the particular force. Using the 𝐿eq values from the extension vs. time fittings we 








Where 𝐿0 is the contour length of DNA in the absence of the drug, and ∆𝐿sat is the maximum 
elongation observed at the particular force when the DNA molecule is saturated with Doxo.  
The fractional binding can be used in accordance with a one-dimensional lattice binding model 
called the McGhee Von Hippel (MGVH) Isotherm57 to obtain Doxo’s dissociation constant at a 
particular force. Please view appendix 4 for more detail of this model and its applications. The 
MGVH model provides the following recursive equation that predicts the fractional binding (𝜃) 
change with concentration (𝐶) as a function of two important binding parameters, the binding 
constant (𝐾d) and the binding site size (𝑛) at a particular force. 
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The fractional binding refers to the fraction of base pairs with ligands bound at equilibrium, 
compared to the maximum bound at saturation. This means it can only hold a value between 0 
and 1. This fitting was done with Microsoft Excel’s Data Analysis tool, solver, with fitting 
parameters 𝐾d and 𝑛.  But to obtain best 𝐾d values for each data set the value of n was extracted 
from literature and was set to a value of 1.4.  𝐾d refers to the concentration in which the DNA is 
50% saturated with Doxo, henceforth meaning that a low dissociation constant is linked to a high 
binding affinity.  
Figure 36 illustrates an example of MGVH fitting (solid line) and the equilibrium extensions that 
were used to estimate the fractional bindings (open circles) for various concentrations of Doxo 

































Figure 36: Extension of DNA upon binding to Doxo in the presence of various concentrations of Doxo 
at 20 pN (open circles) and the best fit to the MGVH isotherm at 20 pN (solid curve). 
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This procedure of fitting the fractional bindings to MGVH model was repeated at 30, 40, and 
50 pN forces to obtain 𝐾d at each force. Figure 37 shows these fittings (solid lines) with the 
equilibrium extensions that are used to estimate the fractional bindings (open circles) at all four 
forces that the constant force measurements were done. As mentioned before, each data point 
is an average measurement from at least 3 separate DNA molecules and the error bars represent 







































Figure 37: Equilibrium extensions associated with the fractional binding of Doxo at various 
concentrations at all four forces studied (open circles) and fits to the MGVH isotherms at 
20, 30, 40, and 50 pN. Each concentration is color coded with different color. 
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Force Dependence of Binding Affinity 
 
Once a value of 𝐾d is obtained for all the different forces we can extrapolate its force dependency 
to obtain a 𝐾d value that is in the absence of force.   
Previous single molecule studies19,22,54,56,58 have shown that the force (𝐹) exponentially facilitates 
the binding of a drug molecule to the DNA by stretching and extending it by a length 𝛥𝑥𝑒𝑞. This 
extension is associated with a single intercalation event and in fact the work done to reduce the 
energy barrier for a single intercalation is represented by 𝐹𝛥𝑥𝑒𝑞. 








Where 𝑘𝐵 is Boltzmann’s constant and T is the temperature in K (294 K in the case of our lab 
which yields 𝑘𝐵𝑇 = 4.06 pNnm). The fitting is done with minimizing 𝜒
2 to find the best fitting 
values of 𝐾𝑑(0) and 𝛥𝑥𝑒𝑞.  
The 𝐾d values were obtained at all the four forces and are represented on the Figure 38 as open 
blue circles. The exponential force dependency is shown as the broken blue line where the y-axis 















The y-axis intercept yields the binding affinity of Doxo in the absence of force, 𝐾𝑑(0) = 1087.3 ± 
187.4 nM. The 𝛥𝑥𝑒𝑞 value that represents the extension of the DNA per a single intercalation 
event was determined to be 𝛥𝑥𝑒𝑞 = 0.40 ± 0.02 nm. The value of 𝛥𝑥𝑒𝑞 obtained for Doxo is 
comparable to that of the ones obtained for the threading intercalator, Ru-ΛΛ-P studied by 
Adam Jabak and Nicholas Brydan19,58. This value is greater than the other classical 
intercalators53,54,56.  
 
Doxo Binding Kinetics (Forthcoming) 
The other parameter obtained from the extension vs time fittings of contact force experiments 
is the total rate, 𝑘𝑡𝑜𝑡, representing the net binding rate of Doxo to the DNA. It is the addition of 













Figure 38: Force dependent analysis of 𝐾d values obtained at various forces using the MGVH fits 
(open circles) extrapolated to get the dissociation constant in the absence of force, 𝐾d(0).  
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drug after reaching equilibrium and from these experiments we can extract the off rates. By 
subtracting these off rates from the total rates, we can obtain the on rates.  
 When the flow is switched from Doxo flow in the experiments to that of the buffer, the buffer 
will facilitate the unbinding of Doxo and flush the drug away. This will result in the length of the 
DNA-Doxo complex to decrease from its equilibrium extension. The length decrease can be 
characterized by an exponential decay equation shown below. 
 𝐿(𝑡) = (𝐿𝑒𝑞 − 𝐿0)𝑒
−𝑘𝑜𝑓𝑓𝑡 + 𝐿0 (7) 
Where 𝐿𝑒𝑞 is the equilibrium extension at that particular for and concentration, 𝐿0 is the contour 
length of DNA at that force in the absence of the drug and 𝑘𝑜𝑓𝑓 is the off rate.  Figure 39 represent 
an example of washing data (open circles) obtained washing away 27 nM Doxo at 20 pN constant 
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Figure 39: Representative wash data obtained washing away the drug after reaching 
equilibrium with 27 nM Doxo at 20 pN. The extension of DNA-Doxo (open circles) fitted 
to equation (7) to obtain the off rate, 𝑘off. 
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Once the 𝐾off value is obtained, the on rates 𝐾on can be extracted through the following 
expression: 
 𝐾tot = 𝐾on + 𝐾off (8) 
Unfortunately, we are not done with completing the analysis of the washing experiments. This 
analysis will be completed and included in the manuscript we are planning on writing.  
 
Supplemental Experiments 
The biggest question still out there is the extensions that we get during the release curves in the 
stretch and release experiments showing similar values as constant force experiments. Does this 
suggest that the melting somehow facilitates the binding of Doxo? If that is the case, can we still 
characterize Doxo as a classical intercalator? To explore this fact our theoretical collaborator 
suggested returning to the stretch and release experiments at a slower pace. The idea behind 
this is to provide the drug enough time to reach equilibrium during each step of the process. 
During the normal stretch and release the DNA is stretched with a 100 nm step size and after 
each step a delay of 75 ms is given. This is to accommodate the time to collect 1000 data points 
and average at each step. To facilitate Doxo binding to reach equilibrium at each step, this step 
delay was increased to 60000 ms, hence calling it a delayed stretching experiment. These delayed 
stretches would only go through the elastic regime because of the time it takes to conduct one 
stretch and release experiment. Although we have done some preliminary experiments, we need 
to do more data analysis and data acquisition to confirm any trend.   
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Discussions 
 
Doxo is one of the most prominently used cancer therapeutics yet the mechanism by which it 
binds at the molecular level is left largely uncharacterized. One prominent way to prevent cancer 
progression is halting DNA replication. In the study, which we have conducted over the past four 
years we have investigated the way in which Doxo binds to the DNA at the single molecule level.  
Based on Doxo’s structure and previous studies it is believed to behave as a classical intercalator 
but our study challenges that notion with clear evidence. Doxo does not only need an extended 
amount of time to bind to DNA but it also seems that the DNA melting also facilitates its binding. 
One way to test whether melting is facilitating the equilibrium is to do delayed stretch 
experiments as discussed in the results section. In these experiments after each 100 nm step we 
take with the DNA we wait for almost a minute to provide enough time to reach equilibrium along 
the stretch. We started these experiments but need more data to confirm what is happening. 
The equilibrium DNA extension upon one intercalation event, ∆𝑥𝑒𝑞= 0.40 ± 0.02 nm, is pretty 
high compared to other classical intercalators studied. Other classical intercalators such as 
Ethidium, and Oxazole Yellow (YO) have ∆𝑥𝑒𝑞 values of 0.25 ± 0.03 nm and 0.23 ± 0.01 nm 
respectively56. On the other hand, the ∆𝑥𝑒𝑞 value for Doxo is comparable to the extensions 
obtained with threading intercalators.  Threading intercalators such as Thiocoraline, and 
(Δ,Δ - Pc)+4 have ∆𝑥𝑒𝑞 values of 0.41 ± 0.01 nm and 0.44 ± 0.04 nm respectively
56. Exemplifying 
the fact that, the length extension of many classical intercalators is much less than that of Doxo. 
Our hypothesis from this is that Doxo could possibly be forming dimers before binding at the 
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micromolar concentration as well, not only the millimolar range as previously described. Further, 
the positively charged Doxo in solution could be interacting with the negatively charged 
backbone of the DNA which leads to groove binding. This could create a two-state binding 
mechanism of Doxo to DNA.  The analysis that we have done is based upon single state binding. 
If there are two states involved, we have to reconsider the fitting models and rethink on how 
proceed further. This becomes a bigger challenge because there are no standards established yet 
to analyze groove binders with optical tweezers. Although there are handful of studies that have 
been done at low forces to characterize groove binding, it has not been completely characterized 
through higher forces at the single molecule level. 
Moving forward, the very first thing to do is to continue the preliminary data acquisition of the 
delayed stretch experiments and see if it matches that of the constant force experiments. If it 
does then we have characterized Doxo’s binding to the DNA at high forces for the first time, 
obtaining binding kinetics and affinity. This would be the first study of such and furthermore of a 
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Appendix 1: Recognizing DNA as the Genetic Material 
 
In 1859 a famous scientist by the name of Charles Darwin pitched a theory in one of the most 
famous scientific pieces of all time, “The Origin of Species”59. Darwin was attempting to propose 
his theory of natural selection, where a species will change in small ways causing a population to 
change over several generations, otherwise known as evolution. He used an example in which he 
stated that whales could be rendered from a bear if given ample conditions  and time59. With the 
explanation being, black bears were known to catch insects by swimming with their mouths open 
which could be related to whales, which are more aquatic in structure and habitat but carries out 
a similar function in the water. He later removed this analogy in later editions of his book when 
the scientific community did not respond the way in which he expected. It was concluded by 
Darwin that organisms possess the ability to change overtime passing on both physical and 
behavioral traits to following generations. This would be scrutinized by scientists for years to 
come and the biggest question raised was: what causes the species to change over time? 
Six years later, Gregor Mendel was studying pea and fuchsias plants in his botanical garden within 
the capitol of Austria, Vienna, to understand the question posed from Darwin’s theory. Mendel’s 
experiments60 with these plants went unrecognized for many years by others not utterly 
understanding its significance. His work introduced the world to proteins, modern genetics, and 
describe the principles of heredity61.  
In 1869, a few hundred miles North into Germany at the Felix Hoppe-Seyler Laboratory 
(figure A1)62, a Swiss doctor named Friedrich Miescher studied leukocytes (white blood cells). He 
was trying to understand proteins and their functions through a chemical isolation experiment. 
 
Appendix | 69 
During these experiments, he stumbled upon a novel substance that was neither that of a protein 









For the years to come Miescher’s finding of nuclein (the mixture of nucleic acids and associated 
proteins) was disregarded and null to the idea that it could hold genetic material. Scientists 
believed it was far too simple to hold all the information of our genome thus proteins continued 
to be the accepted genetic material. (Now scientist give credit to Miescher as the one who 
discovered DNA). Between 1885 and 1901, Albrecht Kossel discovered that DNA composed of 
four bases; adenine (A), cytosine (C), guanine (G), thymine (T) whose chemical structures can be 
seen in figure 110. 
 
Figure A1:  The kitchen of the Tubingen castle where Miescher worked 
on his discovery of DNA. This room formed part of the Hoppe-Seyler's 
Lab. Photo was taken by Paul Sinner in 1879 
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Phoebus Levene, who worked with Kossel continued to work on understanding the DNA 
structure. He discovered that DNA is a long chain molecule that was made up of three 
components; a phosphate, a pentose (five carbon) sugar named deoxyribose, and one of the four 
nitrogenous bases (A, T, C, G). Levene stated that the bonding of the three groups would form 
what is called a nucleotide64. But he incorrectly proposed the tetranucleotide structure, where 4 
of these nucleotides form a small circular molecule, which then repeats to form the long chain 
molecule. Based on the structure he proposed Levene believed that the DNA cannot be the 
genetic material and sided with those who believed protein as the genetic material. 
In 1928 Frederick Griffith would return to the notion of DNA being involved in inheritance. 
Griffiths’ experiments in Liverpool investigated the way in which two strains of bacterium 
affected the lives of mice65.   To conclude the experiment in looking at the effect of the different 
bacterium on the lives of the mice he introduced the theory of competence and a transformation 
principal66. The community took this rather haphazardly not fully adopting it until 1944 when 
Oswald Avery confirmed Griffiths’ hypothesis and research stating that this transforming 
substance was the genetic material of the cell, or DNA67.  
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Appendix 2: Polymer Models describing the dsDNA and ssDNA 
 
The standard DNA stretching curve obtained while stretching dsDNA that is free to rotate is 
believed to go through a phase transition around 65 pN (Figure A2).  This transition is known as 
force induced melting transition, where the dsDNA is converted into mostly ssDNA. The polymer 
models, the Worm-Like Chain (WLC) model (green) that describes the dsDNA and the Freely 
Jointed Chain (FJC) Model that describes ssDNA (blue) is also shown in the plot. These models 


















Figure A2: DNA stretch (black solid) and release (black dashed) are shown 
along with the worm-like chain model (green) that describes dsDNA and 
freely jointed chain model (blue) that describes ssDNA 
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Worm Like Chain Model 
In 1994 it was shown that the force versus extension curve of a dsDNA molecule can be modeled 
after the modified worm-like chain (WLC) model68, a polymer model that is used to describe semi-
rigid polymers. 
In regard to small pN forces, between that of 0.01 and 10pN, DNA will act as an entropic spring 
where the WLC model can accurately describe the DNA by assuming smooth distribution of 
bonding angles.  The model describes the force (𝐹) observed within the DNA with particular 




















Where the contour length broadly defines the length of the molecule when it is at the maximum 
length without being stretched, 𝑘B is the Boltzmann constant, 𝑇 is the temperature and P is the 
persistence length that describes the flexibility of the molecule.  
As the DNA is stretched beyond its contour length under higher forces the approximate solution 
for the extension can be mathematically represented as18: 














Where S is the elastic stretching modulus accounting for how the backbone of the molecule 
extends.    
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Freely Jointed Chain Model 
Double stranded DNA (dsDNA) has a more rigid structure than that of single stranded DNA 
(ssDNA) due to the base pairing and stacking interactions within the molecule. This in turns makes 
for a more rigid molecule overall in the dsDNA form compared to that of the ssDNA. Unlike that 
of the WLC the Freely Jointed Chain Model (FJC) breaks down the molecule into individual parts, 
monomers if you will, what can be connected freely through wide range of bond angles like 
jointed chains.  
An expression for the observable length of ssDNA under a force (𝐹); this can be written as18: 














Where z represents the length of the ssDNA being stretched,  𝐿0,ss, and 𝑃𝑠𝑠 are the contour and 
persistence lengths of ssDNA. 
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Appendix 3: Constant Force Vs Stretch and Release 
  
We did stretch and release of the DNA to different positions with respect to the melting transition 
in the presence of 15 nM Doxo to understand whether the melting facilitates the binding.  
Table 1: The average stretching length from these experiments at each point in the melting transition (MT) are compared with 














Release up to 
the End of MT 
Constant Force 
Measurement 
(pN) (nm) (nm) (nm) (nm) (nm) 
20 0.336 ± 0.003 0.351 ± 0.017 0.357 ± 0.014 0.350 ± 0.011 0.340 ± 0.001 
30 0.342 ± 0.003 0.358 ± 0.018 0.367 ± 0.013 0.356 ± 0.013 0.349 ± 0.003 
40 0.348 ± 0.003 0.365 ± 0.020 0.376 ± 0.013 0.362 ± 0.017 0.360 ± 0.004 
50 0.357 ± 0.005 0.371 ± 0.021 0.384 ± 0.014 0.370 ± 0.013 0.375 ± 0.006 
 
It is clear that stretch and release before reaching the melting transition (blue column) has the 
lowest extension at every force indicating very little Doxo binding. But progressively stretching 
into the transition (green and yellow column) increases the extension indicating more Doxo 
binding at all four forces. But once you start stretching to the end of the transition (red column) 
the extension shrinks back a little bit at all four forces.  
The values obtained with stretch and release through the entire melting transition is similar to 
the equilibrium extension value obtained in the constant force measurements (grey column) 
within uncertainties at all four forces.   
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Appendix 4: McGhee Von-Hippel Isotherm Model 
 
 
In 1974 James McGhee and Peter Von-Hippel created the elegant analytical expression for the 
isotherm describing how a ligand can bind to a lattice like structure. The McGhee Von-Hippel 
(MGVH) Model used three parameters, (1) Intrinsic binding constant, K, (2) Unitless cooperative 
parameter, w, and (3) number of lattice sites covered by a ligand, n to characterize number of 
ligands bound per lattice site. Conditional probabilities were used to obtain the original McGhee 




= 𝐾𝑤(1 − 𝑛𝑣)
1 + (2𝑤 − 𝑛 − 1)𝑣 + 𝑄
(2𝑤 − 1)(1 − 𝑛𝑣) + 𝑣 + 𝑄
[
2𝑤(1 − 𝑛𝑣)
(2𝑤 − 1)(1 − 𝑛𝑣) + 𝑣 + 𝑄
] 
 
Where, 𝑄 =  √(1 − (𝑛 + 1)𝑣2) + 4𝑤𝑣(1 − 𝑛𝑣) 
 
Furthermore, 𝑣 is the number of bound ligands per lattice site holding a value between 0 and 
1/n.  
For the experiments in which we conduct we use the MGVH isotherm to determine a small 
molecule’s binding affinity at a certain force to DNA which can be thought of as a one-
dimensional lattice structure. More simply stated the molecule’s binding affinity just means its 
strength of binding between the ligand (Doxo) and a receptor (DNA), where in parentheses 
regards our specific experiment.  
 
Appendix | 76 
In particularly we are focused with the one-dimensional homogeneous lattice of DNA, meaning 
that non-specific binding of the ligand into the bases of the DNA, which reduces the equation to 
a simpler form20: 











Where 𝐾d is the dissociation constant, C is the concentration, 𝜃 is the fractional equilibrium 
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